4.8 Review

Digital technologies in the public-health response to COVID-19

期刊

NATURE MEDICINE
卷 26, 期 8, 页码 1183-1192

出版社

NATURE PORTFOLIO
DOI: 10.1038/s41591-020-1011-4

关键词

-

资金

  1. EPSRC [EP/R00529X/1]
  2. Google
  3. Microsoft
  4. Telefonica
  5. IRC Next Steps Plus: Ultra-Sensitive Enhanced NanoSensing of Anti-Microbial Resistance (u-sense) [EP/R018391/1]
  6. NIHR
  7. Wellcome Trust
  8. CRUK
  9. EPSRC/MRC/UKRI
  10. H2020
  11. ERC
  12. EPSRC [EP/R00529X/1, EP/K031953/1, EP/R018391/1] Funding Source: UKRI
  13. MRC [MC_PC_19070] Funding Source: UKRI

向作者/读者索取更多资源

Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases. The COVID-19 pandemic has resulted in an accelerated development of applications for digital health, including symptom monitoring and contact tracing. Their potential is wide ranging and must be integrated into conventional approaches to public health for best effect.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据